233 related articles for article (PubMed ID: 23280281)
1. Weekly fluconazole therapy for recurrent vulvovaginal candidiasis: a systematic review and meta-analysis.
Rosa MI; Silva BR; Pires PS; Silva FR; Silva NC; Silva FR; Souza SL; Madeira K; Panatto AP; Medeiros LR
Eur J Obstet Gynecol Reprod Biol; 2013 Apr; 167(2):132-6. PubMed ID: 23280281
[TBL] [Abstract][Full Text] [Related]
2. Interventions for prevention and treatment of vulvovaginal candidiasis in women with HIV infection.
Ray A; Ray S; George AT; Swaminathan N
Cochrane Database Syst Rev; 2011 Aug; (8):CD008739. PubMed ID: 21833970
[TBL] [Abstract][Full Text] [Related]
3. Oral fluconazole and vulvovaginal candidiasis: prevention is not always better than cure.
Prescrire Int; 2013 Sep; 22(141):205. PubMed ID: 24171211
[TBL] [Abstract][Full Text] [Related]
4. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis.
Sobel JD; Wiesenfeld HC; Martens M; Danna P; Hooton TM; Rompalo A; Sperling M; Livengood C; Horowitz B; Von Thron J; Edwards L; Panzer H; Chu TC
N Engl J Med; 2004 Aug; 351(9):876-83. PubMed ID: 15329425
[TBL] [Abstract][Full Text] [Related]
5. Individualized decreasing-dose maintenance fluconazole regimen for recurrent vulvovaginal candidiasis (ReCiDiF trial).
Donders G; Bellen G; Byttebier G; Verguts L; Hinoul P; Walckiers R; Stalpaert M; Vereecken A; Van Eldere J
Am J Obstet Gynecol; 2008 Dec; 199(6):613.e1-9. PubMed ID: 18976735
[TBL] [Abstract][Full Text] [Related]
6. Antifungal (oral and vaginal) therapy for recurrent vulvovaginal candidiasis: a systematic review protocol.
Lírio J; Giraldo PC; Amaral RL; Sarmento ACA; Costa APF; Gonçalves AK
BMJ Open; 2019 May; 9(5):e027489. PubMed ID: 31122991
[TBL] [Abstract][Full Text] [Related]
7. Itraconazole vs fluconazole for the treatment of uncomplicated acute vaginal and vulvovaginal candidiasis in nonpregnant women: a metaanalysis of randomized controlled trials.
Pitsouni E; Iavazzo C; Falagas ME
Am J Obstet Gynecol; 2008 Feb; 198(2):153-60. PubMed ID: 18068146
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of recurrent vulvovaginal candidosis with mycosyst (fluconazole)].
Pekhlivanov B; Amaliev I; Ivancheva Kh; Zisova L
Akush Ginekol (Sofiia); 2005; 44 Suppl 2():25-7. PubMed ID: 16028400
[TBL] [Abstract][Full Text] [Related]
9. Prognosis and Long-Term Outcome of Women With Idiopathic Recurrent Vulvovaginal Candidiasis Caused by Candida albicans.
Collins LM; Moore R; Sobel JD
J Low Genit Tract Dis; 2020 Jan; 24(1):48-52. PubMed ID: 31860575
[TBL] [Abstract][Full Text] [Related]
10. A phase 2, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of orally administered VT-1161 in the treatment of recurrent vulvovaginal candidiasis.
Brand SR; Degenhardt TP; Person K; Sobel JD; Nyirjesy P; Schotzinger RJ; Tavakkol A
Am J Obstet Gynecol; 2018 Jun; 218(6):624.e1-624.e9. PubMed ID: 29534874
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of chronic recurrent vulvovaginal candidiasis with fluconazole (fungolon--Actavis)].
Borisov I; Kolarov G; Bobcheva S; Ivanova A
Akush Ginekol (Sofiia); 2005; 44 Suppl 2():17-20. PubMed ID: 16028398
[TBL] [Abstract][Full Text] [Related]
12. Fluconazole versus 3-day clotrimazole in the treatment of sporadic and recurrent vulvovaginal candidiasis.
Corić M; Barisić D; Lovrić H
Int J Gynaecol Obstet; 2006 Nov; 95(2):171-2. PubMed ID: 16916515
[No Abstract] [Full Text] [Related]
13. An evaluation of butoconazole nitrate 2% site release vaginal cream (Gynazole-1) compared to fluconazole 150 mg tablets (Diflucan) in the time to relief of symptoms in patients with vulvovaginal candidiasis.
Seidman LS; Skokos CK
Infect Dis Obstet Gynecol; 2005 Dec; 13(4):197-206. PubMed ID: 16338779
[TBL] [Abstract][Full Text] [Related]
14. [New study shows probiotics ineffective in prevention of post-antibiotic vaginal candidiasis].
Bern VH
Praxis (Bern 1994); 2004 Oct; 93(44):1 p following 1843. PubMed ID: 15559911
[No Abstract] [Full Text] [Related]
15. Management of chronic vulvovaginal candidiasis: a long term retrospective study.
Nguyen Y; Lee A; Fischer G
Australas J Dermatol; 2017 Nov; 58(4):e188-e192. PubMed ID: 27250078
[TBL] [Abstract][Full Text] [Related]
16. Oteseconazole for the Treatment of Recurrent Vulvovaginal Candidiasis: A Drug Review.
Lanier C; Melton TC
Ann Pharmacother; 2024 Jun; 58(6):636-644. PubMed ID: 37650387
[TBL] [Abstract][Full Text] [Related]
17. Phase 3 study evaluating the safety and efficacy of oteseconazole in the treatment of recurrent vulvovaginal candidiasis and acute vulvovaginal candidiasis infections.
Martens MG; Maximos B; Degenhardt T; Person K; Curelop S; Ghannoum M; Flynt A; Brand SR
Am J Obstet Gynecol; 2022 Dec; 227(6):880.e1-880.e11. PubMed ID: 35863457
[TBL] [Abstract][Full Text] [Related]
18. [Short-course treatment of vulvovaginal candidiasis: comparative study of fluconazole and intra-vaginal fenticonazole].
Murina F; Graziottin A; Felice R; Di Francesco S; Mantegazza V
Minerva Ginecol; 2012 Apr; 64(2):89-94. PubMed ID: 22481619
[TBL] [Abstract][Full Text] [Related]
19. Vaginal nystatin versus oral fluconazole for the treatment for recurrent vulvovaginal candidiasis.
Fan S; Liu X; Wu C; Xu L; Li J
Mycopathologia; 2015 Feb; 179(1-2):95-101. PubMed ID: 25416649
[TBL] [Abstract][Full Text] [Related]
20. Weekly fluconazole to prevent candida.
Gilden D
GMHC Treat Issues; 1996; 10(6/7):16. PubMed ID: 11363636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
